<DOC>
	<DOCNO>NCT00204776</DOCNO>
	<brief_summary>Both capecitabine oxaliplatin single agent activity breast cancer . The combination improve activity solid tumor . This study seek assess activity combination breast cancer .</brief_summary>
	<brief_title>XELOX Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>preserve organ function good performance status one prior therapy active brain metastasis No prior capecitabine oxaliplatin concurrent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>